|
1
|
Tenesa A and Dunlop MG: New insights into
the aetiology of colorectal cancer from genome-wide association
studies. Nat Rev Genet. 10:353–358. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar
|
|
3
|
Labianca R and Merelli B: Screening and
diagnosis for colorectal cancer: Present and future. Tumori.
96:889–901. 2010. View
Article : Google Scholar
|
|
4
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
5
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: Incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar :
|
|
6
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lo Russo G, Tessari A, Capece M, Galli G,
de Braud F, Garassino MC and Palmieri D: MicroRNAs for the
diagnosis and management of malignant pleural mesothelioma: A
literature review. Front Oncol. 8:6502018. View Article : Google Scholar
|
|
8
|
Mollaei H, Safaralizadeh R and Rostami Z:
MicroRNA replacement therapy in cancer. J Cell Physiol.
234:12369–12384. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ors-Kumoglu G, Gulce-Iz S and Biray-Avci
C: Therapeutic microRNAs in human cancer. Cytotechnology.
71:411–425. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kala R, Peek GW, Hardy TM and Tollefsbol
TO: MicroRNAs: An emerging science in cancer epigenetics. J Clin
Bioinforma. 3:62013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stark A, Brennecke J, Bushati N, Russell
RB and Cohen SM: Animal MicroRNAs confer robustness to gene
expression and have a significant impact on 3′UTR evolution. Cell.
123:1133–1146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hede K: Studies define role of microRNA in
cancer. J Natl Cancer Inst. 97:1114–1115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34(Database Issue):
D140–D144. 2006. View Article : Google Scholar :
|
|
14
|
Huang S, Tan X, Huang Z, Chen Z, Lin P and
Fu SW: microRNA biomarkers in colorectal cancer liver metastasis. J
Cancer. 9:3867–3873. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding L, Lan Z and Xiong X: The dual role
of micrornas in colorectal cancer progression. Int J Mol Sci.
19:pii: E2791. 2018. View Article : Google Scholar
|
|
16
|
Yang S, Sun Z, Zhou Q, Wang W, Wang G,
Song J, Li Z, Zhang Z, Chang Y, Xia K, et al: MicroRNAs, long
noncoding RNAs, and circular RNAs: Potential tumor biomarkers and
targets for colorectal cancer. Cancer Manag Res. 10:2249–2257.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Song C, Tang H, Tang H, Zhang C,
Tang J, Li X, Chen B and Xie X: miR-629-3p may serve as a novel
biomarker and potential therapeutic target for lung metastases of
triple-negative breast cancer. Breast Cancer Res. 19:722017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Luo P, Jing W, Zhou H, Liang C
and Tu J: circSMAD2 inhibits the epithelial-mesenchymal transition
by targeting miR-629 in hepatocellular carcinoma. Onco Targets
Ther. 11:2853–2863. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng YQ, Bai YF, Yang S, Cui YR, Wang YP
and Hu WL: MircoRNA-629 promotes proliferation, invasion and
migration of nasopharyngeal carcinoma through targeting PDCD4. Eur
Rev Med Pharmacol Sci. 23:207–216. 2019.PubMed/NCBI
|
|
20
|
Phuah NH, Azmi MN, Awang K and Nagoor NH:
Suppression of microRNA-629 enhances sensitivity of cervical cancer
cells to 1′S-1′-acetoxychavicol acetate via regulating RSU1. Onco
Targets Ther. 10:1695–1705. 2017. View Article : Google Scholar :
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Peröbner I, Karow M, Jochum M and Neth P:
LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic
differentiation in human mesenchymal stem cells. Int J Biochem Cell
Biol. 44:1970–1982. 2012. View Article : Google Scholar
|
|
23
|
Lemieux E, Cagnol S, Beaudry K, Carrier J
and Rivard N: Oncogenic KRAS signalling promotes the Wnt/β-catenin
pathway through LRP6 in colorectal cancer. Oncogene. 34:4914–4927.
2015. View Article : Google Scholar
|
|
24
|
Yang X, Wang L, Wang Q, Li L, Fu Y and Sun
J: MiR-183 inhibits osteosarcoma cell growth and invasion by
regulating LRP6-Wnt/β-catenin signaling pathway. Biochem Biophys
Res Commun. 496:1197–1203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shirafkan N, Mansoori B, Mohammadi A,
Shomali N, Ghasbi M and Baradaran B: MicroRNAs as novel biomarkers
for colorectal cancer: New outlooks. Biomed Pharmacother.
97:1319–1330. 2018. View Article : Google Scholar
|
|
26
|
Masuda T, Hayashi N, Kuroda Y, Ito S,
Eguchi H and Mimori K: MicroRNAs as biomarkers in colorectal
cancer. Cancers (Basel). 9:pii: E124. 2017. View Article : Google Scholar
|
|
27
|
Sarvizadeh M, Malekshahi ZV, Razi E,
Sharifi H, Moussavi N and Taghizadeh M: MicroRNA: A new player in
response to therapy for colorectal cancer. J Cell Physiol.
234:8533–8540. 2019. View Article : Google Scholar
|
|
28
|
Balacescu O, Sur D, Cainap C, Visan S,
Cruceriu D, Manzat-Saplacan R, Muresan MS, Balacescu L, Lisencu C
and Irimie A: The impact of miRNA in colorectal cancer progression
and its liver metastases. Int J Mol Sci. 19:pii: E3711. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shao L, Shen Z, Qian H, Zhou S and Chen Y:
Knockdown of miR-629 inhibits ovarian cancer malignant behaviors by
targeting testis-specific Y-like protein 5. DNA Cell Biol.
36:1108–1116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jingushi K, Ueda Y, Kitae K, Hase H, Egawa
H, Ohshio I, Kawakami R, Kashiwagi Y, Tsukada Y, Kobayashi T, et
al: miR-629 Targets TRIM33 to promote TGFβ/Smad signaling and
metastatic phenotypes in ccRCC. Mol Cancer Res. 13:565–574. 2015.
View Article : Google Scholar
|
|
31
|
Yan H, Li Q, Wu J, Hu W, Jiang J, Shi L,
Yang X, Zhu D, Ji M and Wu C: MiR-629 promotes human pancreatic
cancer progression by targeting FOXO3. Cell Death Dis. 8:e31542017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu CC, Prior J, Piwnica-Worms D and Bu G:
LRP6 overexpression defines a class of breast cancer subtype and is
a target for therapy. Proc Natl Acad Sci USA. 107:5136–5141. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuan Y, Xie X, Jiang Y, Wei Z, Wang P,
Chen F, Li X, Sun C, Zhao H, Zeng X, et al: LRP6 is identified as a
potential prognostic marker for oral squamous cell carcinoma via
MALDI-IMS. Cell Death Dis. 8:e30352017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wen Q, Zhao J, Bai L, Wang T, Zhang H and
Ma Q: miR-126 inhibits papillary thyroid carcinoma growth by
targeting LRP6. Oncol Rep. 34:2202–2210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Du C, Lv Z, Cao L, Ding C, Gyabaah OA, Xie
H, Zhou L, Wu J and Zheng S: MiR-126-3p suppresses tumor metastasis
and angiogenesis of hepatocellular carcinoma by targeting LRP6 and
PIK3R2. J Transl Med. 12:2592014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bhanot P, Brink M, Samos CH, Hsieh JC,
Wang Y, Macke JP, Andrew D, Nathans J and Nusse R: A new member of
the frizzled family from Drosophila functions as a Wingless
receptor. Nature. 382:225–230. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang C, Yao C, Tian R, Zhu Z, Zhao L, Li
P, Chen H, Huang Y, Zhi E, Gong Y, et al: miR-202-3p regulates
sertoli cell proliferation, synthesis function, and apoptosis by
targeting LRP6 and Cyclin D1 of Wnt/β-catenin signaling. Mol Ther
Nucleic Acids. 14:1–19. 2019. View Article : Google Scholar
|
|
38
|
Rismani E, Fazeli MS, Mahmoodzadeh H,
Movassagh A, Azami S, Karimipoor M and Teimoori-Toolabi L: Pattern
of LRP6 gene expression in tumoral tissues of colorectal cancer.
Cancer Biomark. 19:151–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yao Q, An Y, Hou W, Cao YN, Yao MF, Ma NN,
Hou L, Zhang H, Liu HJ and Zhang B: LRP6 promotes invasion and
metastasis of colorectal cancer through cytoskeleton dynamics.
Oncotarget. 8:109632–109645. 2017. View Article : Google Scholar
|
